Elanco Animal Health to Commercialize Vaccine for Dairy Cattle to Battle Bird Flu Outbreak

Dow Jones
2025/02/25
 

By Denny Jacob

 

Elanco Animal Health will commercialize an avian flu vaccine for dairy cattle after reaching an agreement with Medgene.

The developer and manufacturer of pet and farm-animal products said on Tuesday that Medgene reported that its vaccine has met all requirements of the U.S. Agriculture Department's platform technology guidelines and is in the final stages of review for conditional license approval.

Elanco said a cattle vaccine will be critical to slow transmission between birds and cattle, a potential catalyst as a bird flu outbreak has roiled farms and sent egg prices soaring.

"As egg prices soar and milk production wanes in infected dairies, the need for new solutions to curb disease spread is evident," said Elanco Chief Executive Jeff Simmons.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

February 25, 2025 07:39 ET (12:39 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10